1-4 of 4
Wen Di
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer

Available to Purchase
Lin Cheng, Shichao Zhou, Shaoqing Zhou, Kaixuan Shi, Yan Cheng, Mei-Chun Cai, Kaiyan Ye, Lifeng Lin, Zhenfeng Zhang, Chenqiang Jia, Huaijiang Xiang, Jingyu Zang, Meiying Zhang, Xia Yin, Ying Li, Wen Di, Guanglei Zhuang, Li Tan
Journal: Cancer Research
Cancer Res (2022) 82 (19): 3588–3602.
https://doi.org/10.1158/0008-5472.CAN-22-0222
Published: 04 October 2022
View articletitled, Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer
Open the PDF for Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer

Free
Xia Yin, Ying Jing, Mei-Chun Cai, Pengfei Ma, Yi Zhang, Cong Xu, Meiying Zhang, Wen Di, Guanglei Zhuang
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6551–6561.
https://doi.org/10.1158/0008-5472.CAN-17-1461
Published: 30 November 2017
View articletitled, Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer
Open the PDF for Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 3734: Paclitaxel disrupts polarized entry of membrane permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death

Free
Charles Best, David Calianese, Kevin Szulak, Gabriella Brum, Katelyn Higgins, Thomas Carbone, Michael McCauley, Wen Di, Harold Wanebo, Yinsheng Wan
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3734.
https://doi.org/10.1158/1538-7445.AM2012-3734
Published: 15 April 2012
View articletitled, Abstract 3734: Paclitaxel disrupts polarized entry of membrane permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death
Journal Articles

Targeted inhibition of transient activation of EGFR-mediated cell survival pathway enhances paclitaxol-induced ovarian cancer cell death.

Free
Lihua Qiu, Wen Di, Erica Scheffler, Steven Derby, Jian Yang, Bingfang Yan, Harry Wanebo, Yinsheng Wan
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 42.
Published: 01 May 2005
View articletitled, Targeted inhibition of transient activation of EGFR-mediated cell survival pathway enhances paclitaxol-induced ovarian cancer cell death.